0001209191-22-013787.txt : 20220228 0001209191-22-013787.hdr.sgml : 20220228 20220228190802 ACCESSION NUMBER: 0001209191-22-013787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220224 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERLROTH VICTOR CENTRAL INDEX KEY: 0001754181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 22692838 MAIL ADDRESS: STREET 1: 1200 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-24 0 0001468748 Kodiak Sciences Inc. KOD 0001754181 PERLROTH VICTOR 1200 PAGE MILL ROAD PALO ALTO CA 94304 1 1 1 0 Chairman and CEO Common Stock 2022-02-24 4 S 0 1000000 9.2017 D 2508038 D Common Stock 2022-02-25 4 S 0 340000 8.9882 D 2168038 D 2,000,000 shares of common stock owned by the Reporting Person were pledged as collateral to secure obligations under a loan entered into in connection with a previously disclosed Stipulation for Settlement with the Reporting Person's spouse. The sales reported in this Form 4 were sold pursuant to a contractual enforcement action, pursuant to which the pledgee bank unilaterally liquidated the shares. The Reporting Person was not involved in the determination to sell such shares. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.95 to $9.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $8.72 to $9.40, inclusive. /s/ David Peinsipp, Attorney-in-Fact for Victor Perlroth 2022-02-28